Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Astragalus granules combined with ARB for diabetic nephropathy
ChiCTR-IPR-17013482Phase 4Recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Nov 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of astragalus granules in diabetic glomerulosclerosis (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: blood routine, blood biochemistry and 7 more. Started Nov 2017; status: recruiting.
02
Drugs
astragalus granules
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR-IPR-17013482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013482.